VERU INC. Preferred Stock, Shares Authorized
VERU INC. (VERU) had Preferred Stock, Shares Authorized of 154.00 million shares as of 2019-03-31, per its 10-Q filed 2019-05-15.
Discontinued › Balance Sheet › Equity › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2019-08-08
- 2019-03-31: Preferred Stock, Shares Authorized 154.00M shares.
- 2019-03-27: Preferred Stock, Shares Authorized 154.00M shares; Preferred Stock, Shares Authorized as first filed 77.00M shares.
- 2019-03-26: Preferred Stock, Shares Authorized 77.00M shares.
| Period end | Preferred Stock, Shares Authorized | Preferred Stock, Shares Authorized as first filed |
|---|---|---|
| 2019-03-31 | 154.00M shares 10-Q · filed 2019-05-15 | |
| 2019-03-27 | 154.00M shares 10-Q · filed 2019-08-08 | 77.00M shares 10-Q · filed 2019-05-15 |
| 2019-03-26 | 77.00M shares 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |